Skip to main content
. 2019 Sep 3;12:1697–1703. doi: 10.2147/DMSO.S216455

Figure 3.

Figure 3

Protein kinase A (PKA) activity in the liver after treatment with liraglutide. Values are means ± SD (n=6 per group). A 2×2 factorial analysis was used to analyse differences. The p-value of the interaction between obesity and liraglutide treatment in PKA activity is 0.014.

Notes: Between saline and liraglutide, **p<0.01; between normal and obese, ##p<0.01.